Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT06969261
- Status
- Recruiting
Conditions
- Opioid Use Disorder
- Perinatal Opioid Use Disorder
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Penny COPILOT — BEHAVIORALThe Penny COPILOT chatbot is an interactive short messaging system (SMS) program that provides educational and supportive content for postpartum individuals. The chatbot has been adapted to include information relevant to opioid use disorder recovery in order to decrease the risk of returning to use among people who use drugs. Messages are sent at specified intervals relevant to the postpartum course and the chatbot allows for two way messaging with an interactive lens.
Study Details
To address both loneliness and engagement in perinatal and OUD care among perinatal women, the investigators plan to adapt an existing texting support chatbot, Penny, to make it appropriate for use by women who are pregnant and postpartum and dealing with OUD. The newly adapted chatbot, Penny COPILOT, will allow for two way short message service (SMS) messaging to respond appropriately and accurately to user generated input. The investigative team, in collaboration with the Penn Mixed Methods Research Lab (MMRL) and Penn's Way 2 Health Team, will use intervention mapping guided by the Consolidated Framework for Implementation Science. The investigators will conduct a needs assessment, assemble an advisory board, engage in pretesting to ensure safety and refine content, and pilot test the resultant adapted Penny COPILOT in a sample of 20 perinatal women with OUD to evaluate acceptability, feasibility, and patient satisfaction. The goal is to develop and refine an acceptable, feasible, and satisfactory supportive texting chatbot to promote patient engagement in perinatal and OUD care and decrease perceived loneliness.
Key Dates
- Start date
- Jan 1, 2026
- Status verified
- Feb 2026
- Primary completion
- May 31, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Chatbot InterventionThis is a single arm study designed to assess the acceptability and feasibility of the chatbot.
Primary Outcome Measure
UCLA Loneliness Scale. [ Time Frame: During Aim 3 activities, assessments will occur at Baseline and at 3-month Follow-up. ]
Central Contacts
- Sara L Kornfield, PhD1-800-789-7366
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hospital of the University of Pennsylvania (HUP) | Philadelphia | Pennsylvania | 19072 | |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104-3309 |
Find similar trials in Philadelphia, PA
Related Studies
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment EngagementRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in PregnancyRecruiting · Ilana Hull · Pittsburgh, Pennsylvania
- Integrating Brain, Neurocognitive, and Computational Tools in OUDRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania